102 related articles for article (PubMed ID: 22987262)
21. [Susceptibility of Enterococcus genus to new antimicrobial agents].
Sánchez-Molina MI; Martín D; Valladares C; Gastañares MJ; Torres C; Borque L
Rev Esp Quimioter; 2004 Jun; 17(2):184-8. PubMed ID: 15470513
[TBL] [Abstract][Full Text] [Related]
22. Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy.
Zarrilli R; Tripodi MF; Di Popolo A; Fortunato R; Bagattini M; Crispino M; Florio A; Triassi M; Utili R
J Antimicrob Chemother; 2005 Nov; 56(5):827-35. PubMed ID: 16186168
[TBL] [Abstract][Full Text] [Related]
23. [Antimicrobial resistance in clinical patterns of Pseudomonas aeruginosa].
del Mar Casal M; Causse M; Rodríguez-López F; Casal M
Rev Esp Quimioter; 2012 Mar; 25(1):37-41. PubMed ID: 22488540
[TBL] [Abstract][Full Text] [Related]
24. Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.
Till M; Wixson RL; Pertel PE
Clin Infect Dis; 2002 May; 34(10):1412-4. PubMed ID: 11981739
[TBL] [Abstract][Full Text] [Related]
25. High incidence of vancomycin resistance in Enterococcus faecalis strains in a French hospital.
Garnier F; Ducancelle A; Boisset S; Pineiro A; Bergeret M; Denis F; Raymond J
Int J Antimicrob Agents; 2004 May; 23(5):529-30. PubMed ID: 15120739
[No Abstract] [Full Text] [Related]
26. Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faecium.
Pai MP; Rodvold KA; Schreckenberger PC; Gonzales RD; Petrolatti JM; Quinn JP
Clin Infect Dis; 2002 Nov; 35(10):1269-72. PubMed ID: 12410489
[TBL] [Abstract][Full Text] [Related]
27. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.
Johnson AP; Tysall L; Stockdale MV; Woodford N; Kaufmann ME; Warner M; Livermore DM; Asboth F; Allerberger FJ
Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):751-4. PubMed ID: 12415476
[TBL] [Abstract][Full Text] [Related]
28. High Prevalence of vanM in Vancomycin-Resistant Enterococcus faecium Isolates from Shanghai, China.
Chen C; Sun J; Guo Y; Lin D; Guo Q; Hu F; Zhu D; Xu X; Wang M
Antimicrob Agents Chemother; 2015 Dec; 59(12):7795-8. PubMed ID: 26369966
[TBL] [Abstract][Full Text] [Related]
29. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium in a paediatric unit at a Turkish university hospital.
Ergani-Ozcan A; Naas T; Baysan BO; Ogunc D; Inan D; Colak D; Nordmann P
J Antimicrob Chemother; 2008 May; 61(5):1033-9. PubMed ID: 18319236
[TBL] [Abstract][Full Text] [Related]
30. A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.
Johnson PD; Ballard SA; Grabsch EA; Stinear TP; Seemann T; Young HL; Grayson ML; Howden BP
J Infect Dis; 2010 Oct; 202(8):1278-86. PubMed ID: 20812846
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of vancomycin-resistant enterococci in hospitalized patients and those living in the community in the Czech Republic.
Kolar M; Pantucek R; Vagnerova I; Sauer P; Kesselova M; Cekanova L; Koukalova D; Doskar J; Ruzickova V
New Microbiol; 2006 Apr; 29(2):121-5. PubMed ID: 16841552
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of microdilution method and Phoenix automated system for testing antimicrobial susceptibilities of Enterococcus strains].
Gülmez D; Hasçelik G
Mikrobiyol Bul; 2011 Jan; 45(1):21-7. PubMed ID: 21341155
[TBL] [Abstract][Full Text] [Related]
33. [In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].
Efe S; Sinirtaş M; Ozakin C
Mikrobiyol Bul; 2009 Oct; 43(4):639-43. PubMed ID: 20084917
[TBL] [Abstract][Full Text] [Related]
34. Linezolid-resistant, vancomycin-resistant Enterococcus faecium infection in patients without prior exposure to linezolid.
Rahim S; Pillai SK; Gold HS; Venkataraman L; Inglima K; Press RA
Clin Infect Dis; 2003 Jun; 36(11):E146-8. PubMed ID: 12766857
[TBL] [Abstract][Full Text] [Related]
35. Enterococcus faecium isolated from bone marrow transplant patients in Tunisia: high prevalence of antimicrobial resistance and low pathogenic power.
Abbassi MS; Achour W; Touati A; Ben Hassen A
Pathol Biol (Paris); 2009 May; 57(3):268-71. PubMed ID: 18394823
[TBL] [Abstract][Full Text] [Related]
36. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of virulence factors and antibiotic resistance in vancomycin-resistant Enterococcus faecium isolated from sewage and clinical samples in Iran.
Jahangiri S; Talebi M; Eslami G; Pourshafie MR
Indian J Med Microbiol; 2010; 28(4):337-41. PubMed ID: 20966565
[TBL] [Abstract][Full Text] [Related]
38. In vitro activities of tigecycline, daptomycin, linezolid and quinupristin/dalfopristin against glycopeptide-resistant Enterococcus faecium.
Abb J
Int J Antimicrob Agents; 2007 Mar; 29(3):358-60. PubMed ID: 17229553
[No Abstract] [Full Text] [Related]
39. Trimethoprim resistance genes in vancomycin-resistant Enterococcus faecium clinical isolates from France.
Cattoir V; Huynh TM; Bourdon N; Auzou M; Leclercq R
Int J Antimicrob Agents; 2009 Oct; 34(4):390-2. PubMed ID: 19619988
[No Abstract] [Full Text] [Related]
40. Nosocomial spread of Enterococcus faecium resistant to vancomycin and linezolid in a tertiary care medical center.
Dobbs TE; Patel M; Waites KB; Moser SA; Stamm AM; Hoesley CJ
J Clin Microbiol; 2006 Sep; 44(9):3368-70. PubMed ID: 16954275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
